Chemomab Therapeutics Ltd. (CMMB)

Chemomab Therapeutics Statistics

Total Valuation

CMMB has a market cap or net worth of $10.43 million. The enterprise value is $782,012.

Market Cap	10.43M
Enterprise Value	782,012

Important Dates

The last earnings date was Thursday, March 19, 2026, before market open.

Earnings Date	Mar 19, 2026
Ex-Dividend Date	n/a

Share Statistics

CMMB has 7.19 million shares outstanding. The number of shares has increased by 42.11% in one year.

Current Share Class	n/a
Shares Outstanding	7.19M
Shares Change (YoY)	+42.11%
Shares Change (QoQ)	+26.76%
Owned by Insiders (%)	11.52%
Owned by Institutions (%)	9.07%
Float	6.36M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.90
P/TBV Ratio	0.90
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 9.08

Current Ratio	9.08
Quick Ratio	9.08
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -69.54% and return on invested capital (ROIC) is -45.65%.

Return on Equity (ROE)	-69.54%
Return on Assets (ROA)	-38.86%
Return on Invested Capital (ROIC)	-45.65%
Return on Capital Employed (ROCE)	-77.57%
Weighted Average Cost of Capital (WACC)	7.23%
Revenue Per Employee	n/a
Profits Per Employee	-$449,750
Employee Count	20
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -68.75% in the last 52 weeks. The beta is 0.54, so CMMB's price volatility has been lower than the market average.

Beta (5Y)	0.54
52-Week Price Change	-68.75%
50-Day Moving Average	1.70
200-Day Moving Average	2.85
Relative Strength Index (RSI)	37.05
Average Volume (20 Days)	52,668

Short Selling Information

The latest short interest is 40,790, so 0.67% of the outstanding shares have been sold short.

Short Interest	40,790
Short Previous Month	54,874
Short % of Shares Out	0.67%
Short % of Float	n/a
Short Ratio (days to cover)	0.37

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-9.57M
Pretax Income	-9.00M
Net Income	-9.00M
EBITDA	-9.51M
EBIT	-9.57M
Earnings Per Share (EPS)	-$1.41

Balance Sheet

The company has $10.37 million in cash and n/a in debt, with a net cash position of $10.37 million or $1.44 per share.

Cash & Cash Equivalents	10.37M
Total Debt	n/a
Net Cash	10.37M
Net Cash Per Share	$1.44
Equity (Book Value)	12.33M
Book Value Per Share	1.71
Working Capital	11.95M

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Depreciation & Amortization	53,000
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CMMB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-42.11%
Shareholder Yield	-42.11%
Earnings Yield	-80.69%
FCF Yield	n/a

Analyst Forecast

The average price target for CMMB is $25.00, which is 1,624.14% higher than the current price. The consensus rating is "Buy".

Price Target	$25.00
Price Target Difference	1,624.14%
Analyst Consensus	Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-29.84%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 26, 2025. It was a reverse split with a ratio of 1:4.

Last Split Date	Aug 26, 2025
Split Type	Reverse
Split Ratio	1:4

Scores

Altman Z-Score	n/a
Piotroski F-Score	1